US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 1.5950
  • -0.0150-0.93%
Trading Mar 17 14:58 ET
14.72MMarket Cap-0.25P/E (TTM)

About SAB Biotherapeutics Company

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.

Company Profile

SymbolSABS
Company NameSAB Biotherapeutics
Listing DateFeb 9, 2021
Founded2014
CEOMr. Samuel J. Reich
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address777 West 41st Street,Suite 401
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33140
Phone1-605-679-6980

Company Executives

  • Name
  • Position
  • Salary
  • Samuel J. Reich
  • Chief Executive Officer and Director
  • 565.80K
  • Lucy To
  • Chief Financial Officer
  • --
  • Christoph Lawrence Bausch
  • Chief Operating Officer
  • 549.32K
  • Dr. Alexandra Kropotova, M.D.
  • Chief Medical Officer and Executive Vice President
  • 921.58K
  • Mark William Conley, C.P.A.
  • Vice President, Finance
  • --
  • David Link, M.B.A.
  • Vice Chairman of the Board
  • 25.00K
  • Dr. Eddie J. Sullivan, PhD
  • Director and President
  • 202.60K
  • Dr. Jay S. Skyler,M.D.,M.A.C.P.
  • Director
  • --
  • Dr. William J. Polvino, M.D.
  • Independent Director
  • 25.00K
  • Christine Hamilton, M.B.A.
  • Independent Director
  • 25.00K
  • Andrew D. Moin
  • Independent Director
  • --
  • Helen Katherine Ellias
  • Independent Director
  • --
  • Jeffrey G. Spragens
  • Independent Director
  • 25.00K
  • Erick J. Lucera, C.F.A.
  • Independent Director
  • 26.93K
  • Admiral Scott Giberson, (Ret.)
  • Independent Director
  • 25.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More